Impact of Pain on Cognitive Functions in Primary Sjögren Syndrome with Small Fiber Neuropathy: 10 Cases and a Literature Review

Overview

Journal Medicine (Baltimore)

Specialty General Medicine

Date 2017 Apr 20

PMID 28422829

Citations 10

Authors

Sandrine Indart

Jacques Hugon

Pierre Jean Guillausseau

Alice Gilbert

Julien Dumurgier

Claire Paquet

Damien Sene

Affiliations

Soon will be listed here.

Abstract

Primary Sjögren syndrome (pSS) is a chronic systemic autoimmune disease characterized by xerophthalmia, xerostomia, and potential peripheral or central neurological involvement. In pSS, the prevalence of cognitive disorders is generally sparse across literature and the impact of pain on cognitive profile is unclear. The aim of this study was to determine the relation between pain, cognitive complaint, and impairment in a very homogenous population of 10 pSS patients with painful small fiber neuropathy (PSFN) and spontaneous cognitive complaint. Neurological exam, neuropsychological assessment, clinical evaluation measuring pain level, fatigue, anxiety, depression, and cognitive complaint were performed. Our results showed that 100% of patients had cognitive dysfunction especially in executive domain (80%). The most sensitive test was the Wisconsin Card Sorting Test (WCST), abnormal in 70% of our population. Moreover, we found clear cut significant correlations between pain levels and 3 measures of WCST: the number of errors (R = -0.768, P = .0062), perseverations (R = 0.831, P = .0042), and categories (R = 0.705, P = .02). In the literature review, the impact of pain is underexplored and results could be discordant. In a homogeneous cohort of pSS patients with PSFN, a cognitive complaint seems to be a valid reflection of cognitive dysfunction marked by a specific executive profile found with the WCST. In this preliminary study, this profile is linked to the level of pain and highlights that an appropriate management of pain control and a cognitive readaptation in patients could improve the quality of life.

Citing Articles

Neurocognitive and Neuropsychiatric Implications of Fibrosing Interstitial Lung Diseases.

Vastag Z, Tudorache E, Traila D, Fira-Mladinescu O, Marc M, Oancea C Biomedicines. 2024; 12(11).

PMID: 39595138 PMC: 11591599. DOI: 10.3390/biomedicines12112572.

Neurological and Psychiatric Clinical Manifestations of Sjögren Syndrome.

Popescu A, Hickernell J, Paulson A, Aouhab Z Curr Neurol Neurosci Rep. 2024; 24(8):293-301.

PMID: 38981949 DOI: 10.1007/s11910-024-01352-z.

Exploring the Psychiatric Manifestations of Primary Sjögren's Syndrome: A Narrative Review.

Salehi M, Zamiri A, Kim J, Texeira C, Shah K, Gunturu S Int J Rheumatol. 2024; 2024:5520927.

PMID: 38774059 PMC: 11108699. DOI: 10.1155/2024/5520927.

Defining Dry Eye from a Clinical Perspective.

Tsubota K, Pflugfelder S, Liu Z, Baudouin C, Kim H, Messmer E Int J Mol Sci. 2020; 21(23).

PMID: 33291796 PMC: 7730816. DOI: 10.3390/ijms21239271.

Cognitive impairment in patients with Neuro-Sjögren.

Seeliger T, Jacobsen L, Hendel M, Bonig L, Kristian Prenzler N, Thiele T Ann Clin Transl Neurol. 2020; 7(8):1352-1359.

PMID: 32628345 PMC: 7448149. DOI: 10.1002/acn3.51123.

References

Lafitte C, Amoura Z, Cacoub P, Pradat-Diehl P, Picq C, Salachas F . Neurological complications of primary Sjögren's syndrome. J Neurol. 2001; 248(7):577-84. DOI: 10.1007/s004150170135. View

Blanc F, Fleury M, Korganow A, Cremel N, De Seze J, Sellal F . [Cognition disorders and associated behaviors associated with Gougerot-Sjögren syndrome]. Rev Neurol (Paris). 2010; 165 Spec No 4:F267-72. View

Cancelli I, Beltrame M, Gigli G, Valente M . Drugs with anticholinergic properties: cognitive and neuropsychiatric side-effects in elderly patients. Neurol Sci. 2009; 30(2):87-92. DOI: 10.1007/s10072-009-0033-y. View

Segal B, Mueller B, Zhu X, Prosser R, Pogatchnik B, Holker E . Disruption of brain white matter microstructure in primary Sjögren's syndrome: evidence from diffusion tensor imaging. Rheumatology (Oxford). 2010; 49(8):1530-9. DOI: 10.1093/rheumatology/keq070. View

Verdejo-Garcia A, Lopez-Torrecillas F, Calandre E, Delgado-Rodriguez A, Bechara A . Executive function and decision-making in women with fibromyalgia. Arch Clin Neuropsychol. 2009; 24(1):113-22. DOI: 10.1093/arclin/acp014. View

Berryman C, Stanton T, Bowering K, Tabor A, McFarlane A, Moseley G . Evidence for working memory deficits in chronic pain: a systematic review and meta-analysis. Pain. 2013; 154(8):1181-96. DOI: 10.1016/j.pain.2013.03.002. View

Moriarty O, McGuire B, Finn D . The effect of pain on cognitive function: a review of clinical and preclinical research. Prog Neurobiol. 2011; 93(3):385-404. DOI: 10.1016/j.pneurobio.2011.01.002. View

Petersen R . Clinical practice. Mild cognitive impairment. N Engl J Med. 2011; 364(23):2227-34. DOI: 10.1056/NEJMcp0910237. View

Carvajal Alegria G, Guellec D, Mariette X, Gottenberg J, Dernis E, Dubost J . Epidemiology of neurological manifestations in Sjögren's syndrome: data from the French ASSESS Cohort. RMD Open. 2016; 2(1):e000179. PMC: 4838763. DOI: 10.1136/rmdopen-2015-000179. View

10.

Folstein M, Folstein S, McHugh P . "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975; 12(3):189-98. DOI: 10.1016/0022-3956(75)90026-6. View

11.

Segal B, Rhodus N, Sivils K, Solid C . Validation of the brief cognitive symptoms index in Sjögren syndrome. J Rheumatol. 2014; 41(10):2027-33. DOI: 10.3899/jrheum.140362. View

12.

Malinow K, Molina R, Gordon B, Selnes O, Provost T, Alexander E . Neuropsychiatric dysfunction in primary Sjögren's syndrome. Ann Intern Med. 1985; 103(3):344-50. DOI: 10.7326/0003-4819-103-3-344. View

13.

Sene D, Cacoub P, Authier F, Haroche J, Creange A, Saadoun D . Sjögren Syndrome-Associated Small Fiber Neuropathy: Characterization From a Prospective Series of 40 Cases. Medicine (Baltimore). 2013; 92(5):e10-e18. PMC: 4553978. DOI: 10.1097/MD.0000000000000005. View

14.

Mahieux-Laurent F, Fabre C, Galbrun E, Dubrulle A, Moroni C . [Validation of a brief screening scale evaluating praxic abilities for use in memory clinics. Evaluation in 419 controls, 127 mild cognitive impairment and 320 demented patients]. Rev Neurol (Paris). 2009; 165(6-7):560-7. DOI: 10.1016/j.neurol.2008.11.016. View

15.

Epstein L, Masse G, Harmatz J, Scott T, Papas A, Greenblatt D . Characterization of cognitive dysfunction in Sjögren's syndrome patients. Clin Rheumatol. 2013; 33(4):511-21. DOI: 10.1007/s10067-013-2453-6. View

16.

Lauvsnes M, Maroni S, Appenzeller S, Beyer M, Greve O, Kvaloy J . Memory dysfunction in primary Sjögren's syndrome is associated with anti-NR2 antibodies. Arthritis Rheum. 2013; 65(12):3209-17. DOI: 10.1002/art.38127. View

17.

Martinez S, Caceres C, Mataro M, Escudero D, Latorre P, Davalos A . Is there progressive cognitive dysfunction in Sjögren Syndrome? A preliminary study. Acta Neurol Scand. 2010; 122(3):182-8. DOI: 10.1111/j.1600-0404.2009.01293.x. View

18.

Delalande S, De Seze J, Fauchais A, Hachulla E, Stojkovic T, Ferriby D . Neurologic manifestations in primary Sjögren syndrome: a study of 82 patients. Medicine (Baltimore). 2004; 83(5):280-291. DOI: 10.1097/01.md.0000141099.53742.16. View

19.

Segal B, Pogatchnik B, Holker E, Liu H, Sloan J, Rhodus N . Primary Sjogren's syndrome: cognitive symptoms, mood, and cognitive performance. Acta Neurol Scand. 2011; 125(4):272-8. PMC: 3188671. DOI: 10.1111/j.1600-0404.2011.01530.x. View

20.

Zigmond A, SNAITH R . The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983; 67(6):361-70. DOI: 10.1111/j.1600-0447.1983.tb09716.x. View